DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Novavax
Novavax
28Th WHO Regulatory Update on COVID-19
Update on Approved and Candidate COVID-19 Vaccines in the EU
Ebola4
Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
INTERNATIONAL STUDENT COVID VACCINE LIST and COMMUNICATION Dear International Student
NOVAVAX, INC. (Exact Name of Registrant As Specified in Its Charter)
Partnerships Key to Combating Viral Epidemics
Annual Report 2019 to Our Shareholders
Novavax Corporate Investor Deck
Novavax COVID-19 Vaccine Contract
Learning from Ebola: How Drug-Development Policy Could Help Stop Outbreaks of Infectious Diseases*
Racing Against COVID-19: a Vaccines Strategy for Europe
Vaccine Efficacy from 7 Days After Second Dose
Vaxart's Oral Vaccine Is Room Temperature Stable
Explaining Operation Warp Speed
Appendix Q: COVID-19 Vaccines
First-In-Human Clinical Trial Initiated for Novel Malaria Transmission Blocking Vaccine
Operation Warp Speed Contracts for COVID 19 Vaccines
Top View
Advanced Research & Development to Large Scale Manufacturing Of
Commission Approves New Contract for a Potential COVID-19 Vaccine
COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System As a Potential Vaccine Platform
COVID-19 Vaccine Briefing Science Based Forecasts for the Short- and Long-Term
COVID-19 Vaccines: a Review of the Safety and Efficacy of Current
Frequently Asked Questions About COVID-19 Candidate Vaccines and Access Mechanisms
(GP) Nanoparticle Vaccine Candidate Update: NHP and Clinical Data
STUDY PROTOCOL V122 01 Version 1.0
Efficacy and Safety of COVID-19 Vaccines: a Systematic Review and Meta-Analysis of Randomized Clinical Trials
PR – Prevent 19 Phase 3 – Trial Results
Rapid Manufacture and Release of a GMP Batch of Zaire Ebolavirus Glycoprotein Vaccine Made Using Recombinant Baculovirus-Sf9 Insect Cell Culture Technology
World Health Organization (WHO) Emergency Use Authorization (EUA) Qualified COVID-19 Vaccines
COVID-19 Vaccines By: Richard Jefferys, Treatment Action Group
Download (Accessed June 2, 2020
Immunization Covid-19 Update
SARS-Cov-2 Protein Subunit Vaccines
DRAFT Landscape of COVID-19 Candidate Vaccines – 15 October 2020
Proven Technology in Vaccine Production
Vaccines in Clinical Evaluation? 4 Vaccine
Novartis Announces Positive Clinical Trial Results for Novel H7N9 Vaccine
Neutralization of SARS-Cov-2 VOC 501Y.V2 by Human Antisera Elicited by Both
Gao-21-319, Operation Warp Speed
Update with the Development of Ebola Vaccines and Implications of Emerging Evidence to Inform Future Policy Recommendations
Review of “Safety and Efficacy of NVX-Cov2373 COVID-19 Vaccine”
Operation Warp Speed at Two Months
COVID-19 Vaccination: Should I?
Jama Murray 2021 Vp 210033
21-12 How COVID-19 Vaccine Supply Chains Emerged in the Midst of a Pandemic
The Potential of Recombinant Nanoparticle Vaccines Produced in a Baculovirus Insect Cell System
A Systematic Review of Universal Influenza Vaccines in Clinical Trials
Oxford™S Malaria Vaccine Shows Significant 75% Efficacy in Early Trial
1 1 2 3 4 5 6 7 8 Bengtsson 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Ra Capital's Covid-19 Map